Cross-source evidence timeline
Eloralintide research timeline
Follow 20 selected, directly cited source records from November 19, 2025 through November 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT07935304↗
PeptideScanner retained ClinicalTrials.gov record NCT07935304 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07282600↗
PeptideScanner retained ClinicalTrials.gov record NCT07282600 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07353931↗
PeptideScanner retained ClinicalTrials.gov record NCT07353931 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07369011↗
PeptideScanner retained ClinicalTrials.gov record NCT07369011 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07392190↗
PeptideScanner retained ClinicalTrials.gov record NCT07392190 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07900633↗
PeptideScanner retained ClinicalTrials.gov record NCT07900633 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07215559↗
PeptideScanner retained ClinicalTrials.gov record NCT07215559 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-09, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07589608↗
PeptideScanner retained ClinicalTrials.gov record NCT07589608 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07808060↗
PeptideScanner retained ClinicalTrials.gov record NCT07808060 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07701083↗
PeptideScanner retained ClinicalTrials.gov record NCT07701083 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07321886↗
PeptideScanner retained ClinicalTrials.gov record NCT07321886 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-22, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07738614↗
PeptideScanner retained ClinicalTrials.gov record NCT07738614 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-20, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07426380↗
PeptideScanner retained ClinicalTrials.gov record NCT07426380 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-19, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Literature metadata
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.↗
PubMed lists PMID 41559929 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase I, Multicenter Study, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug eloralintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 20, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07765511↗
PeptideScanner retained ClinicalTrials.gov record NCT07765511 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07665879↗
PeptideScanner retained ClinicalTrials.gov record NCT07665879 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06230523↗
PeptideScanner retained ClinicalTrials.gov record NCT06230523 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-24, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07401862↗
PeptideScanner retained ClinicalTrials.gov record NCT07401862 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06916065↗
PeptideScanner retained ClinicalTrials.gov record NCT06916065 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT06916091↗
PeptideScanner retained ClinicalTrials.gov record NCT06916091 at 2026-11-16T01:48:01.052Z. Its registry update date was 2025-11-19, and PeptideScanner's reviewed identity mapping was eloralintide.↗
Added to PeptideScanner November 16, 2026